BioSpace News Archive

LogixHealth has released its 2020 Emergency Department Physician Update, a comprehensive review of Medicare’s 2020 Physician Fee Schedule Final Rule.

Kineticos announced today the Kineticos Disruptor Fund , a new life sciences investment fund. The fund will invest in disruptive modalities including cell therapy approches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies.

Belong.Life, creator of the Belong - Beating Cancer Together mobile app, will share a study tomorrow at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando showing that cancer patients who had discussions with their doctors about the financial challenges of receiving immunotherapy before beginning treatment were 37.5% more likely to avoid financial toxicity when receiving cancer immunotherapy treatments.

The clinical trials initiated in the United States and in Israel will evaluate safety, tolerability and efficacy of PrimeC, NeuroSense’s product for ALS patients.

The french engineering company FIBROLINE has developed and patented a portfolio of powder impregnation technologies for all types of porous materials.

Atlantic Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted over-the-counter (OTC) clearance to INNOVO®, a non-invasive, clinically proven and wearable device that treats the root cause of bladder weakness, known clinically as stress urinary incontinence (SUI).

Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for Alzheimer’s disease (AD) and related neurodegenerative disorders, announces that the company will be presenting at two conferences this month.

Feb. 6, 2020 14:00 UTC VIENNA, Va.--( BUSINESS WIRE )-- CEL-SCI Corporation (NYSE American: CVM) , a Phase 3 cancer immunotherapy company, announced today that Geert Kersten, Chief Executive Officer, will be presenting at the 2020 BIO CEO & Investor Conference in New York, NY on Monday, February 10, 2019 at 3:45 p.m.

With global health concerns regarding the 2019 Novel Coronavirus (2019-nCoV) continuing to rise, hospital administrators and healthcare professionals are evaluating their options for providing patients with blood products that have an added level of safety.

Feb. 6, 2020 14:00 UTC Leading neurobiologist Dr. Greg Hickok, neuroscientist Dr. Robert Bowser, FDA and regulatory expert Michele Chin-Purcell and data analytics strategist Tyler Knutson added to the board SCOTTSDALE, Ariz.--( BUSINESS WIRE )-- Aural Analytics, Inc. , a privately held digital health company developing the world’s most advanced speech analytics platform, today announced the appointments of Greg Hickok, Ph.D. , professor of cognitive sciences at the Univ